Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts

Blood, Vol. 112, Issue 13, 5150-5160, December 15, 2008
This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

Etiologic heterogeneity among non-Hodgkin lymphoma subtypes
Blood Morton et al. 112: 5150

Supplemental materials for: Morton et al

Files in this Data Supplement:

  • Table S1. Exposure assessment for selected environmental risk factors in the NCI-SEER multi-center case–control study of non-Hodgkin lymphoma (PDF, 75 KB)

  • Table S2. Selected characteristics of population controls and cases, by non-Hodgkin lymphoma subtype, from the NCI-SEER multi-center case–control study of non-Hodgkin lymphoma (PDF, 42.8 KB)

  • Table S3. P-values from each of 7 dichotomous logistic regression models (PDF, 117 KB) -
    Assessing significance of effect of environmental and genetic exposures predicting all possible pair-wise comparisons for 4 NHL subtypes: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), marginal zone lymphoma (MZ), and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).

    REFERENCES

    1. Chatterjee N, Hartge P, Cerhan JR et al. Risk of non-Hodgkin’s lymphoma and family history of lymphatic, hematologic, and other cancers. Cancer Epidemiol Biomarkers Prev 2004;13:1415–21.
    2. Engels EA, Cerhan JR, Linet MS et al. Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin’s lymphoma: a case-control study. Am J Epidemiol 2005;162:1153–61.
    3. Cozen W, Cerhan J, Martinez-Maza O et al. The effect of atopy, childhood crowding, and other immune-related factors on non-Hodgkin lymphoma risk. Cancer Causes Control 2007;18:821–31.
    4. Cerhan JR, Engels EA, Cozen W et al. Blood transfusion, anesthesia, surgery and risk of non-Hodgkin lymphoma in a population-based case-control study. (Submitted) 2007.
    5. Cerhan JR, Bernstein L, Severson RK et al. Anthropometrics, physical activity, related medical conditions, and the risk of non-Hodgkin lymphoma. Cancer Causes Control 2005;16:1203–14.
    6. Morton LM, Hartge P, Holford TR et al. Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the InterLymph consortium. Cancer Epidemiol Biomarkers Prev 2005;14:925–33.
    7. Morton LM, Zheng T, Holford TR et al. Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol 2005;6:469–76.
    8. Lim U, Schenk M, Kelemen LE et al. Dietary determinants of one-carbon metabolism and the risk of non-Hodgkin’s lymphoma: NCI-SEER case-control study, 1998–2000. Am J Epidemiol 2005;162:953–64.
    9. Kelemen LE, Cerhan JR, Lim U et al. Vegetables, fruit, and antioxidant-related nutrients and risk of non-Hodgkin lymphoma: a National Cancer Institute-Surveillance, Epidemiology, and End Results population-based case-control study. Am J Clin Nutr 2006;83:1401–10.
    10. Cross AJ, Ward MH, Schenk M et al. Meat and meat-mutagen intake and risk of non-Hodgkin lymphoma: results from a NCI-SEER case-control study. Carcinogenesis 2006;27:293–7.
    11. Hartge P, Lim U, Freedman DM et al. Ultraviolet radiation, dietary vitamin D, and risk of non-Hodgkin lymphoma (United States). Cancer Causes Control 2006;17:1045–52.
    12. Colt JS, Davis S, Severson RK et al. Residential insecticide use and risk of non-Hodgkin’s lymphoma. Cancer Epidemiol Biomarkers Prev 2006;15:251–7.
    13. Lubin JH, Colt JS, Camann D et al. Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health Perspect 2004;112:1691-6.
    14. Morton LM, Bernstein L, Wang SS et al. Hair dye use, genetic variation in N-acetyl transferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma. Carcinogenesis 2007;28:1759-64.
    15. Hill DA, Wang SS, Cerhan JR et al. Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes. Blood 2006;108:3161–7.
    16. Wang SS, Cerhan JR, Hartge P et al. Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. Cancer Res 2006;66:9771–80.
    17. Lim U, Wang SS, Hartge P et al. Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER Case-Control Study. Blood 2007;109:3050–9.




This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020